The Latest Research

A landmark study has been published in The Lancet which shows that adverse drug reactions (ADRs) were reduced by 30% in individuals who had their drug treatment guided by pharmacogenomics. Read here

Guidelines & More

myDNA ensures the clinical reporting of pharmacogenomic results is based, where possible, on the most published PGx guidelines, such as the Clinical Pharmacogenetics Implementation Consortium (CPIC) and the Royal Dutch Pharmacists Association - Pharmacogenetics Working Group (DPWG). These guidelines are routinely updated, peer-reviewed, and published in relevant journals and can be accessed here,

The US Food and Drug Administration (FDA) has also recently published a list of medications with pharmacogenomic associations and recommendations, which are referenced, where relevant, in the myDNA PGx report:

Downloadable Resources

PGx FedEx Shipping Instructions